Is routine 24-hour urine calcium measurement useful during the evaluation of primary hyperparathyroidism?

被引:9
作者
Li, Shimena R. [1 ]
McCoy, Kelly L. [1 ,2 ]
Levitt, Helena E. [3 ]
Kelley, Meghan L. [2 ]
Carty, Sally E. [1 ,2 ]
Yip, Linwah [1 ]
机构
[1] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Div Endocrine Surg, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA
关键词
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; SENSING RECEPTOR GENE; GUIDELINES; MANAGEMENT; DISORDERS; DIAGNOSIS; EXCRETION; MUTATION;
D O I
10.1016/j.surg.2021.04.055
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Primary hyperparathyroidism and familial hypocalciuric hypercalcemia have similar biochemical profiles, and calcium-to-creatinine-clearance ratio helps distinguish the two. Additionally, 24-hour urine calcium >400 mg/day indicates surgery and guidelines recommend obtaining 24-hour urine calcium preoperatively. Our aim was to assess how 24-hour urine calcium altered care in the evaluation of suspected primary hyperparathyroidism. Methods: Consecutive patients assessed for primary hyperparathyroidism from 2018 to 2020 were reviewed. Primary hyperparathyroidism was diagnosed by 2016 American Association of Endocrine Surgeons Parathyroidectomy Guidelines criteria. 24-hour urine calcium-directed change in care was defined as familial hypocalciuric hypercalcemia diagnosis, surgical deferment for additional testing, or 24-hour urine calcium >400 mg/day as the sole surgical indication. Results: Of 613 patients, 565 (92%) completed 24-hour urine calcium and 477 (84%) had concurrent biochemical testing to calculate calcium-to-creatinine-clearance ratio. 24-hour urine calcium was <100 mg/day in 9% (49/565) and calcium-to-creatinine-clearance ratio was <0.01 in 17% (82/477). No patient had confirmed familial hypocalciuric hypercalcemia, although 1 had a CASR variant of undetermined significance. When calcium-to-creatinine-clearance ratio was <0.01, familial hypocalciuric hypercalcemia was excluded by 24-hour urine calcium >100 mg/day (56%), prior normal calcium (16%), renal insufficiency (11%), absence of familial hypercalcemia (3%), normal repeat 24-hour urine calcium (10%), or interfering diuretic (1%). 24-hour urine calcium-directed change in care occurred in 25 (4%), including 4 (1%) who had genetic testing. Four-gland hyperplasia was more common with calcium-to-creatinineclearance ratio <0.01 (17% vs calcium-to-creatinine-clearance ratio > 0.01, 4%, P < .001), but surgical failure rates were equivalent (P 1/4 .24). Conclusion: 24-hour urine calcium compliance was high, and results affected management in 4%, including productive identification of hypercalciuria as the sole surgical indication in 2 patients. When calcium-to-creatinine-clearance ratio <0.01, clinical assessment was sufficient to exclude familial hypocalciuric hypercalcemia and only 1% required genetic testing. 24-hour urine calcium should be ordered judiciously during primary hyperparathyroidism assessment. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 19 条
[1]   Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia [J].
Bertocchio, Jean-Philippe ;
Tafflet, Muriel ;
Koumakis, Eugenie ;
Maruani, Gerard ;
Vargas-Poussou, Rosa ;
Silve, Caroline ;
Nissen, Peter H. ;
Baron, Stephanie ;
Prot-Bertoye, Caroline ;
Courbebaisse, Marie ;
Souberbielle, Jean-Claude ;
Rejnmark, Lars ;
Cormier, Catherine ;
Houillier, Pascal .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07) :2534-2542
[2]   Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism [J].
Bhangu, Jagdeep Singh ;
Selberherr, Andreas ;
Brammen, Lindsay ;
Scheuba, Christian ;
Riss, Philipp .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05) :1372-1378
[3]   Hyperparathyroidism [J].
Bilezikian, John P. ;
Bandeira, Leonardo ;
Khan, Aliya ;
Cusano, Natalie E. .
LANCET, 2018, 391 (10116) :168-178
[4]   Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop [J].
Bilezikian, John P. ;
Brandi, Maria Luisa ;
Eastell, Richard ;
Silverberg, Shonni J. ;
Udelsman, Robert ;
Marcocci, Claudio ;
Potts, John T., Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) :3561-3569
[5]   Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods [J].
Christensen, Signe Engkjaer ;
Nissen, Peter H. ;
Vestergaard, Peter ;
Heickendorff, Lene ;
Brixen, Kim ;
Mosekilde, Leif .
CLINICAL ENDOCRINOLOGY, 2008, 69 (05) :713-720
[6]   Epidemiology of Primary Hyperparathyroidism [J].
Clarke, Bart L. .
JOURNAL OF CLINICAL DENSITOMETRY, 2013, 16 (01) :8-13
[7]   A Novel Mutation of the Calcium Sensing Receptor Gene in a Franconian Kindred: Heterozygous Mutation c.1697_1698delTG Exon 6 [J].
Cordes, M. ;
Kuwert, T. ;
Haag, C. ;
Raue, F. .
HORMONE AND METABOLIC RESEARCH, 2017, 49 (02) :142-146
[8]   Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop [J].
Eastell, Richard ;
Brandi, Maria Luisa ;
Costa, Aline G. ;
D'Amour, Pierre ;
Shoback, Dolores M. ;
Thakker, Rajesh V. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) :3570-3579
[9]   The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases [J].
Hannan, Fadil M. ;
Kallay, Enikoe ;
Chang, Wenhan ;
Brandi, Maria Luisa ;
Thakker, Rajesh V. .
NATURE REVIEWS ENDOCRINOLOGY, 2018, 15 (01) :33-51
[10]   Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis [J].
Hannan, Fadil M. ;
Babinsky, Valerie N. ;
Thakker, Rajesh V. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 57 (03) :R127-R142